Samsung Medical Center
Seoul, South Korea
Location status: Recruiting
NCT Number: NCT06837324
The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Glove by comparing the effects between a group using the home-based Neofect Smart Glove and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.
Interested in participating?
Request Info19 year–85 year
All sexes
Interventional
Not applicable
Seoul, South Korea
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a total of 20 sessions of home-based upper limb rehabilitation training using the Neofect Smart Glove, with 30 minutes per session, 1 session per day, 5 days a week, for 4 weeks.
a total of 20 sessions of home-based upper limb rehabilitation training using the workbook provided by the research team , with 30 minutes per session, 1 session per day, 5 days a week, for 4 weeeks.
Time frame: Within 14 days before the intervention, within 2 days after intervention
The total score ranges from 0 to 66, with higher scores indicating better motor function. This outcome reports the change in score, calculated as: (Score at Post-intervention) minus (Score at Baseline).
Contact information is provided by the study sponsor or research team.
Samsung Medical Center
Other
A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial
Acronym: brain disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06837363
Brain Diseases, Brain Disorder
Seoul, South Korea
View Trial DetailsNCT05892510
Brain Diseases, Brain Disorder
Gold Coast, Queensland, Australia
View Trial DetailsNCT07397767
Brain Diseases, Brain Disorder
Seoul, South Korea
View Trial DetailsNCT03209258
Anticoagulant-induced Bleeding, Brain Diseases
Chengdu, Sichuan, China
View Trial Details